Forum at UT Southwestern to focus on new therapeutic approaches to Alzheimer's disease

DALLAS — Nov 10, 2008 — The Friends of the Alzheimer’s Disease Center will hold its Fall Public Forum on Nov. 18 at UT Southwestern Medical Center. The presentation will be on “Alzheimer’s Disease: New Hope on the Horizon Through Biomedical Research.”

The speaker will be Dr. Steven Paul, executive vice president of science and technology and president of the Lilly Research Laboratories of Eli Lilly Co.

The 7 p.m. forum in the Simmons/Hamon Biomedical Research Buildings on UT Southwestern’s North Campus, 6000 Harry Hines Blvd., is open to the public at no charge.

Dr. Paul will discuss the basic causes and risks of Alzheimer’s disease and how recent scientific advances in genetics and neuroimaging have contributed to our understanding of the disease process. He also will elaborate on several novel therapeutic approaches being tested that were made possible by these scientific advances.

“Dr. Paul is one of the world’s eminent researchers in Alzheimer's disease,” said Dr. Roger Rosenberg, director of the Alzheimer’s Disease Center at UT Southwestern and holder of the Abe (Brunky), Morris and William Zale Distinguished Chair in Neurology. “Lilly is a major pharmaceutical company that is focusing its resources on new approaches to developing innovative therapies for Alzheimer's disease, and Dr. Paul has an essential role in that process.”

Complimentary valet parking will be available for the forum but seating is limited, and attendance should be confirmed by calling the
UT Southwestern Office of Development at 214-648-2344.

The Friends of the Alzheimer’s Disease Center was established in 1996 to provide financial support for Alzheimer’s research at the medical center. All of the group’s membership contributions go directly to support Alzheimer’s research at UT Southwestern.

Since its founding, the group has raised more than $750,000 for grants to researchers. Membership begins at $500 annually and may be sent to Friends of the Alzheimer’s Disease Center, UT Southwestern Medical Center, P.O. Box 910888, Dallas, TX 75391-0888.

Members receive a newsletter and are invited to attend educational programs to learn about breakthroughs from leading scientists at UT Southwestern and other institutions.



Media Contact: Erin Prather Stafford

To automatically receive news releases from UT Southwestern via e-mail, subscribe at